Brochure | October 31, 2018

From Trial Design To CDISC Submission

Source: Cytel
research collaboration

Background

  • The sponsor is a virtually structured, specialty pharmaceutical company focused on the development and commercialization of novel therapies for the treatment of patients with musculoskeletal conditions.
  • The company’s lead product candidate is being investigated for its potential to provide improved analgesic therapy for a highly prevalent indication.
  • At the time of contracting with Cytel, the company’s lead candidate was entering Phase 2 of development.

The Challenge
Manage multiple, complex statistical analysis deliverables for a program of studies, CDISC compliant outputs, and data pooling for NDA submission to the FDA with minimal sponsor oversight.

VIEW THE BROCHURE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: